
CStone Pharmaceuticals
HKEX:2616

Intrinsic Value
The intrinsic value of one
CStone Pharmaceuticals
stock under the Base Case scenario is
3.47
HKD.
Compared to the current market price of 4.23 HKD,
CStone Pharmaceuticals
is
Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CStone Pharmaceuticals
Fundamental Analysis


Revenue & Expenses Breakdown
CStone Pharmaceuticals
Balance Sheet Decomposition
CStone Pharmaceuticals
Current Assets | 1.1B |
Cash & Short-Term Investments | 672.9m |
Receivables | 83.9m |
Other Current Assets | 333m |
Non-Current Assets | 303.6m |
Long-Term Investments | 9m |
PP&E | 130.5m |
Intangibles | 161.4m |
Other Non-Current Assets | 2.6m |
Free Cash Flow Analysis
CStone Pharmaceuticals
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
CStone Pharmaceuticals
Revenue
|
407.2m
CNY
|
Cost of Revenue
|
-167.1m
CNY
|
Gross Profit
|
240.2m
CNY
|
Operating Expenses
|
-322.1m
CNY
|
Operating Income
|
-81.9m
CNY
|
Other Expenses
|
-9.3m
CNY
|
Net Income
|
-91.2m
CNY
|
Profitability Score
Profitability Due Diligence
CStone Pharmaceuticals's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Score
CStone Pharmaceuticals's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CStone Pharmaceuticals's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Score
CStone Pharmaceuticals's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CStone Pharmaceuticals
According to Wall Street analysts, the average 1-year price target for
CStone Pharmaceuticals
is 2.83 HKD
with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.
Dividends
Current shareholder yield for CStone Pharmaceuticals is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CStone Pharmaceuticals
stock under the Base Case scenario is
3.47
HKD.
Compared to the current market price of 4.23 HKD,
CStone Pharmaceuticals
is
Overvalued by 18%.